Skip to main content
Brad Rovin, MD, Nephrology, Columbus, OH

Brad H Rovin MD

Glomerular Disease


Physician

Join to view full profile
  • 543 Taylor AveColumbus, OH 43203

  • Phone+1 614-293-4837

  • Fax+1 614-293-3125

Dr. Rovin is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Nephrology, 1989 - 1989
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1983 - 1986
  • University of Illinois College of Medicine
    University of Illinois College of MedicineClass of 1983

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 1990 - 2028
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Nephrology
    American Board of Internal Medicine Nephrology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis  
    Richard Furie, Brad H Rovin, The New England Journal of Medicine
  • A Randomized, Controlled Double-Blind Study Comparing the Efficacy and Safety of Dose-Ranging Voclosporin with Placebo in Achieving Remission in Patients with Active L...  
    Brad H Rovin, William F Pendergraft, Kidney International
  • Peripheral Blood B Cell Depletion After Rituximab and Complete Response in Lupus Nephritis  
    Matthew D Cascino, Jay Garg, Paul Brunetta, Tamiko R Katsumoto, Paul Brakeman, Brad Rovin, Leonard Dragone, Richard John Looney, Journal of the American Society of Nephrology

Lectures

  • Case Studies in Glomerular Disease 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019
  • A Prospective Observational Cohort Study Highlights Kidney Biopsy Findings of Lupus Nephritis Patients in Remission Who Flare Following Withdrawal of Maintenance Therapy 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019

Other

Press Mentions

  • National Kidney Foundation 2026 Awards and Honors
    National Kidney Foundation 2026 Awards and HonorsApril 28th, 2026
  • ACR 2025: Key Highlights in Systemic Lupus and Lupus Nephritis
    ACR 2025: Key Highlights in Systemic Lupus and Lupus NephritisNovember 4th, 2025
  • KDIGO Issues New Guideline for Managing IgAN and IgAV
    KDIGO Issues New Guideline for Managing IgAN and IgAVOctober 6th, 2025

Grant Support

  • Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
  • Lupus Omics Cutaneous Kidney Investigative Team (LOCKIT)NEW YORK UNIVERSITY SCHOOL OF MEDICINE2022–2026
  • Muscle-Kidney Crosstalk in Age-related Kidney DiseaseOHIO STATE UNIVERSITY2020–2026
  • Targeting Aberrant Expression of Cytokines/Chemokines for an Inflammatory Nephritis CureOHIO STATE UNIVERSITY2022–2025
  • Forecasters Of Futute And Progressive CDK In Patients With Microvascular GlomerulNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: